The Barbara Gross Research Unit
Royal Hospital for Women, Sydney
Improving quality of life through pioneering health research
About the Barbara Gross Research Unit
The BGRU was established in 1997 to improve women’s quality of life through pioneering health research. The BGRU has particular research strengths in the areas of menopause, osteoporosis, reproductive health and ageing, as well as facilitating the development of innovative surgical techniques for use in clinical practice. The unit provides leadership in the development, enhancement and promotion of women’s health research with a special focus on interdisciplinary and collaborative research.
The BGRU facilitates multi-disciplinary research in women’s health by:
- Developing and sustaining a successful women’s health research program;
- Assisting in the development of innovative research for major pharmaceutical companies and newer pioneering companies involved in the manufacture of drugs/devices/complementary medicines for women’s health;
- Fostering collaborations locally, nationally and internationally in projects with other research organisations and across other disciplines;
- Co-ordinating multi-disciplinary initiatives in promoting women’s health;
- Seeking funding opportunities to support our research.
The Barbara Gross Research Unit is a distinctive medical research organisation in several ways.
First, through its services to companies, it maintains a stable funding base for its own in-house research. health issues.
Second, it addresses a broad range of women’s health issues.
Third, it undertakes medical, surgical, allied health or complementary medicinal research in an open-minded way designed to build an evidence base for women’s health education and medical interventions.
Forth, it is staffed by a truly multi-disciplinary team with world-class expertise in treatment and innovation.
Ground Floor, Royal Hospital for Women.
Barker st. Randwock,
Phone Number: (02) 9382 6621
Any information about you that is obtained in connection with a research study will remain confidential and will be disclosed only with your permission. To ensure confidentiality of the patient, patient information will be identified only by initials, date of birth and a study allocated number. However, the results of the study may be published or disclosed to other people in a way that will not identify you. The study will be conducted in accordance all relevant national and international regulatory guidelines to minimise negative impact on participants. Your medical records insofar as they relate to this study may be reviewed by officials of government related bodies or of any commercial company involved in this study. However, no personal details will be released. All data will be stored by the Barbara Gross Research Unit of the Royal Hospital for Women, under controlled (locked) access. Data will be retained for a minimum of ten years. Materials (including paper documents, and computer discs) will be destroyed using an industrial shredding process.
Adapted from the NSW Privacy and Personal Information Protection Act 1998, sections 8-19.